Published in Cancer Weekly, May 25th, 2010
"A group of 108 consecutive subjects (65 affected by low-risk NMIBC and 43 controls) were selected for this prospective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.